Retinal and Choroidal Changes After Anti-Vegf Therapy in Neovascular-Amd Patients: A Systematic Review and Meta-Analysis of Sd-Oct Studies Publisher Pubmed



Salehi MA¹ ; Frounchi N^{2, 4} ; Zakavi SS^{3, 4} ; Mohammadi S¹ ; Harandi H^{1, 5} ; Shojaei S¹ ; Gouravani M¹ ; Fernando Arevalo J⁶ Show Affiliations
Source: Survey of Ophthalmology Published:2024

Abstract

Background: In recent years, the progress made in the field of optical coherence tomography has helped to understand the changes in eye layers in patients with exudative age-related macular degeneration (nAMD). Early diagnosis of nAMD, a leading cause of irreversible vision impairment, is helpful. Therefore, we performed a meta-analysis on OCT measurement alterations before and after anti-VEGF therapy in patients with nAMD and controls. Method: We systematically searched Scopus, PubMed, Cochrane, and Web of Science to find articles that measured choroidal and retinal layer changes after anti-VEGF therapy in nAMD Patients. We chose either a fixed-effects or random-effects model based on the assessed heterogeneity level to perform a meta-analysis. In addition, we conducted meta-regression, subgroup analyses, publication bias, and quality assessment for included studies. Results: Thirteen studies were included in the meta-analysis, with 733 total participants. Foveal thickness and subfoveal choroidal thickness (CT) decreased significantly in the first 3 years after injections, except for subfoveal CT in the third year after injection. It also showed that CT at 1500 µm temporal and nasal to the fovea did not significantly change. Conclusion: Our results showed anti-VEGF treatment for nAMD patients was associated with a significant reduction in foveal thickness and subfoveal CT in the first 2 years after treatment. Our analysis did not reveal any correlation between changes in foveal thickness and subfoveal CT with best-corrected visual acuity or other factors. © 2024 Elsevier Inc.